Oxaliplatin is a platinum derivative that has shown efficacy in advanced hepatocellular carcinoma. S-1 is an oral fluoropyrimidine that has substituted for 5-fluorouracil in many cancers. | A phase II trial of S-1 and oxaliplatin in patients with advanced hepatocellular carcinoma